Press Releases

  • June 24, 2016 New Product Release MTI-GlobalStem Launches PluriQ™ G9™ Gene Editing System and PluriQ™ G9™ Cloning Medium for Maximum Efficiency CRISPR Gene Editing in Pluripotent Stem Cells-View Full Press Release
  • Nov 6, 2015 - MTI-GlobalStem Announces Collaboration for First Commercial in vitro Human Test System for Neuroprotection in Proteopathic Diseases, Such As Alzheimer’s and Parkinson’s Diseases: Today, MTI-GlobalStem, a provider of human induced pluripotent stem (iPS) cells and optimized neuronal differentiation reagents and protocols, announces its collaboration with SynAging, Nancy, France, a contract research organization (CRO) providing innovative models to investigate neurodegenerative diseases. This collaboration, which started in 2014, has resulted in SynAging’s highly reproducible neuroprotection assays on human neurons for drug developers in Alzheimer’s disease (AD) and Parkinson’s disease (PD). - Learn More 
  • Jul 21, 2015 - New MTI-GlobalStem Website & Corporate Logo: GlobalStem was formed in 2006 and acquired by Molecular Transfer, Inc. (MTI) in 2009. The formation of MTI‐GlobalStem merged MTI’s groundbreaking technologies in the areas of transfection and gene delivery, with GlobalStem’s expertise in stem cell and neurobiology. The new corporate identity, which includes rebranding as MTI‐GlobalStem, a new corporate logo, and a combined, redesigned website, reflects the complete merger of the companies into a cohesive customer experience. MTI‐GlobalStem is a leading supplier of cutting‐edge tools and reagents for the life sciences.  - Learn More
  • Dec. 2014: Molecular Transfer  (GlobalStem) launches  a new portfolio of transfection reagents , under a new DNA-In brand name, and developed under a novel, next-generation technology and IP.  
  • Dec. 2014: Sigma-Aldrich,  a leading,  global life science and high technology company,  launches GlobalStem's new  GS21 Neural Supplement and NeuralQ Basal Media products as part of a strategic co-marketing agreement between the two organizations.
  • Nov. 18, 2014 - GlobalStem nominated for the "Company the to Watch" Award at The Science Advisory Board gala ceremony held during the 2014 Society for Neuroscience Annual Meeting.  The 3,000+ member Science Advisory Board recognizes the world's top performing life science supplier companies! - Learn More 
  • Oct..  2014 -  Molecular Transfer,inc, dba GlobalStem signs co-marketing agreement with Biotime, is a biotechnology company in the field of regenerative medicine headquartered in Alameda, CA. The agreement allows both organization to market//promote a new iPSC Reprogramming Kit scheduled for release in early 2015.
  • Mar.  2014 - Molecular Transfer and GlobalStem combined multiple sites into newly renovated 17,600 sq. ft facility in Gaithersburg, MD
  • Mar. 5 2013 - New Product Release - GlobalStem introduces GS21™ Neural Supplement, a new generation serum-free supplement specially formulated to improve cell survival, synapse development and maturation and overall performance of neuronal cells during short and long -term culture.
  • Oct. 24, 2012 - New Product Release -GlobalStem launches pre-validated Reprogramming-Qualified Newborn Human Fibroblast (NuFF™-RQ) for supporting the generation of induced pluripotent stem cell (iPSC) colonies.
  • Mar 26, 2012 - New Product Release - GlobalStem announces commercial launch of PluriQ™ Serum Replacement for pluripotent stem cell culturing.
  • Dec. 21, 2011 - GlobalStem partners with BI Biotech India - GlobalStem establishes LIFE TECHNOLOGIES (INDIA) PVT. LTD as their distributor in India, including distribution in South Asia and Middle East. 
  • Nov. 9, 2011 - GlobalStem Reveals New Website -GlobalStem launches a new website featuring expanded product information and a new streamlined user experience.  The new website is an important step in growth of GlobalStem's business and expanded marketing strategy.
  • Sept. 5, 2011 - New Product Release - GlobalStem launches GeneIn™, a novel transfection reagent for Hard-to-Transfect cell lines.  GeneIn™ is the first new product from a proprietary transfection chemistry platform developed at MTI-GlobalStem (patent pending).
  • May 1, 2011 - GlobalStem Expands Manufacturing  CapabilitiesGlobalStem doubles its manufacturing facility to meet the increase in product sales and growing demand of it customers.
  • Nov. 15, 2009 - Molecular Transfer, Inc Acquires GlobalStem - Molecular Transfer, Inc.(MTI) today announced that it has acquired GlobalStem, a provider of stem cell reagents and services. This acquisition will allow MTI to move quickly into the stem cell market using GlobalStem’s strong market presence and experienced stem cell and neuroscience scientific team.  VIEW
  • Feb. 25, 2009 - GlobalStem partners with CHDI Foundation -CHDI Foundation (Princeton, NJ) has entered an agreement with GlobalStem to comprehensively expand, authenticate and bank mouse embryonic stem (ES) cell lines that model Huntington's disease. 
  • Nov. 12, 2007 - GlobalStem Receives SBIR Grants - GlobalStem is awarded two Phase 1 SBIR grants by the U.S. National Institutes of Health (NIH). Funding will allow GlobalStem to create genetically modified human feeder cells for the support of undifferentiated hESC.